Development of CMX001 for the Treatment of Poxvirus Infections
Abstract
Share and Cite
Lanier, R.; Trost, L.; Tippin, T.; Lampert, B.; Robertson, A.; Foster, S.; Rose, M.; Painter, W.; O’Mahony, R.; Almond, M.; et al. Development of CMX001 for the Treatment of Poxvirus Infections. Viruses 2010, 2, 2740-2762. https://doi.org/10.3390/v2122740
Lanier R, Trost L, Tippin T, Lampert B, Robertson A, Foster S, Rose M, Painter W, O’Mahony R, Almond M, et al. Development of CMX001 for the Treatment of Poxvirus Infections. Viruses. 2010; 2(12):2740-2762. https://doi.org/10.3390/v2122740
Chicago/Turabian StyleLanier, Randall, Lawrence Trost, Tim Tippin, Bernhard Lampert, Alice Robertson, Scott Foster, Michelle Rose, Wendy Painter, Rose O’Mahony, Merrick Almond, and et al. 2010. "Development of CMX001 for the Treatment of Poxvirus Infections" Viruses 2, no. 12: 2740-2762. https://doi.org/10.3390/v2122740